Media Database
>
Josh Sandberg

Josh Sandberg

President/CEO at OrthoSpineNews

Contact this person
Email address
i*****@*******.comGet email address
Influence score
38
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

orthospinenews.com

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by Siemens to Showcase Advancing Technologies in the MRI Space The RSNA Edition Coincides With the Annual Meeting of the Radiology Society of North America (RSNA) BROOMFIELD, Colo., Nov. …
orthospinenews.com

The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S...

TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of commercializing its innovative RemeOs™ Trauma Products in the U.S. market. Bioretec strengthens its operational efforts by entering into a new logistics agreement with a partner providing customer support services for U.S. operations. …
orthospinenews.com

Spineart Celebrates 100,000 Ti-Life Technology Cages Sold Worldwide

Geneva, November 19, 2024 – Spineart, a leader in spine surgery innovation, today announces that it has reached the significant milestone of 100,000 Ti-LIFE Technology cages sold worldwide, supporting the Company’s mission to transform spine surgery for surgeons, patients and hospitals in more than 60 global markets. Launched in July 2016, Spineart’s Ti-LIFE Technology is …
orthospinenews.com

Spine Surgery Products Market Size to Hit USD 20.0 Billion by 2031 ...

Demand for spine surgery products will rise as robotics and artificial intelligence become increasingly integrated into spine surgery. Wilmington, Delaware, United States, Transparency Market Research, Inc., Nov. 11, 2024 (GLOBE NEWSWIRE) — The spine surgery products industry (industri produk pembedahan tulang belakang) was valued at US$ 13.3 billion in 2022. A CAGR of 4.5% is forecast from 2023 to 2031, reaching US$ 20.0 …
orthospinenews.com

Medtech developer StarFish Medical acquires California-based Omnica...

This is the company’s second acquisition in seven years and brings StarFish Medical closer to clients in California — a major center of medical device innovation.  VICTORIA, BC and TORONTO, Nov. 4, 2024 /PRNewswire/ – StarFish Medical, a leading North American full-service medical device development company, announced today that it has acquired Omnica Corporation, a Southern California powerhouse in medical device design and engineering.  …
orthospinenews.com

Doctors, facing another pay cut in 2025, call for permanent Medicar...

November 2, 2024 – By Heather Landi  “There needs to be a systematic reform that makes Medicare payment rational, predictable and sustainable,” AMA president Bruce Scott, M.D. said. The Centers for Medicare and Medicaid Services (CMS) is moving forward with a 2.9% cut to physician payments in 2025 despite protest from major industry groups. CMS announced …
orthospinenews.com

Lazurite Welcomes Dr. Jacob Calcei as Medical Advisor

CLEVELAND, October 23, 2024 –(BUSINESS WIRE)– Lazurite, a leader in innovative surgical technologies and the company behind the FDA-approved ArthroFree® Wireless Camera System, is proud to announce the appointment of Dr. Jacob Calcei as a Medical Advisor. A highly respected orthopedic sports medicine physician and shoulder surgeon, Dr. Calcei is a Sports Medicine Orthopedic Surgeon …
orthospinenews.com

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Brings 30+ years of commercial experience in the orthopedic and spine industry BURLINGTON, Mass., October 21, 2024 –(BUSINESS WIRE)– Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the appointment of Phillip T. Meikle to the Company’s board of directors, effective immediately. Mr. …
orthospinenews.com

VSI Spine Surgeons Reach Milestone: 100th Augmented Reality-Assiste...

The team of five pioneering spine surgeons at VSI leads the way with augmented reality-assisted spine surgery, enhancing precision and patient safety in spinal procedures. For over 30 years, VSI has been at the forefront of surgical innovation, continuously bringing the most advanced and effective techniques to the operating room. RESTON, Va., Oct. 9, 2024 /PRNewswire/ — …
orthospinenews.com

Smith+Nephew partners with JointVue™ for Ultrasound preoperative pl...

Patented technology further personalizes total knee arthroplasty for surgeons and patients October 9, 2024, Smith+Nephew, (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D Surgery Planning Technology – the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s …
orthospinenews.com

Inside information: Bioretec updates its product development strate...

TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ — Bioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage, an innovative medical device engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company’s proprietary magnesium alloy. The decision to accelerate the product development of the RemeOs™ Spinal Interbody Cage is based on …
orthospinenews.com

HHS investing $75 million in rural healthcare infrastructure

The focus will be on ensuring rural communities have access to primary care, emergency services and specialty care. September 26, 2024 – Jeff Lagasse, Editor – In a move designed to strengthen healthcare access and infrastructure in underserved areas, the Department of Health and Human Services has announced a $75 million investment in rural healthcare. This initiative aims …
orthospinenews.com

Synergy Spine Solutions announces completion of patient enrollment ...

LOUISVILLE, Colo., Sept. 25, 2024 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopedic medical device developer focused on artificial cervical disc replacement, today announced that it has completed patient enrollment in its U.S. 2-Level IDE clinical trial. Conducted under a U.S. Investigational Device Exemption (IDE), the 2-Level trial will evaluate the safety and effectiveness of the Synergy …
orthospinenews.com

Spine BioPharma, Inc. Announces Completion of Enrollment for Phase ...

NEW YORK, September 24, 2024 –(BUSINESS WIRE)– Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced the completion of enrollment of its U.S. Phase 3 clinical trial of SB-01 For Injection (SB-01). The Phase 3 MODEL trial (MOderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine) …
orthospinenews.com

eCential Robotics Appoints Experienced Leadership Team to Drive U.S...

NASHVILLE, Tenn., Sept. 19, 2024 /PRNewswire/ — eCential Robotics, a growth company transforming bone surgery by designing and manufacturing an open robotic and navigation system with unique capabilities, is pleased to announce the addition of Lisa Jacobs and Matthieu Ville to its leadership team. These strategic hires come as part of eCential Robotics’ commitment to accelerating its growth and innovation in the U.S. …
orthospinenews.com

Leap Distributors Acquires Leap Surgical and DUB Enterprises: Partn...

DALLAS, Sept. 19, 2024 /OrthoSpineNews/ – Leap Distributors has acquired Leap Surgical and DUB Enterprises, two privately owned and nationally recognized medical device firms. Effective immediately, the three companies will operate as one under the Leap Distributors umbrella, with headquarters in Dallas, additional offices in Houston and a national customer base. “We’re thrilled to unite …
orthospinenews.com

X-Bolt Receives Prestigious ‘Best Technology in Spine’ Award from O...

DUBLIN, Sept. 16, 2024 /PRNewswire/ — X-Bolt Orthopedics, an emerging innovator of bone fixation implants in orthopedics, has been awarded the Best Technology In Spine Award for 2024/2025 by Orthopedics This Week. This award honors the unsung heroes in the world of medical technology — the inventors, engineers, and innovators who dedicate countless hours to advancing spine surgery. The DragonBoltÔ …
orthospinenews.com

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatm...

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) — PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare technology company focused on chronic low back pain, Aclarion is at the forefront of developing noninvasive tools to help physicians identify the source of pain in spinal discs, …
orthospinenews.com

Aclarion Provides Corporate Update on Nociscan AI Technology Milest...

Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing chronic low back pain, the largest expenditure in US healthcare costing Americans an estimated $134 Billion annually More than $50 Million has been invested in the promising Aclarion AI platform that aids …
orthospinenews.com

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled Trial in Norway Comparing Lumbar Interbody Fusion Surgery With Multidisciplinary Rehabilitation LIFEHAB Joins the NIH and Rome in Selecting Nociscan as a Technology to Help Determine Which …
orthospinenews.com

New bond financing agreement in a minimum amount of €3 million in a...

Disclaimer: SAFE SA (the “Company”) has arranged financing in the form of convertible bonds into new or existing shares (OCEANE) with Global Corporate Finance Opportunities 20 (“GCFO 20”), which, after receiving the shares resulting from the conversion of these bonds, is not intended to remain a shareholder of the Company.The shares resulting from the conversion …